Literature DB >> 10913022

Synthesis rate of plasma albumin is a good indicator of liver albumin synthesis in sepsis.

B Ruot1, D Breuillé, F Rambourdin, G Bayle, P Capitan, C Obled.   

Abstract

Plasma albumin is well known to decrease in response to inflammation. The rate of albumin synthesis from both liver and plasma was measured in vivo by use of a large dose of L-[(2)H(3)-(14)C]valine in rats injected intravenously with live Escherichia coli and in pair-fed control rats during the acute-phase period (2 days postinfection). The plasma albumin concentration was reduced by 50% in infected rats compared with pair-fed animals. Infection induced a fall in both liver albumin mRNA levels and albumin synthesis relative to total liver protein synthesis. However, absolute liver albumin synthesis rate (ASR) was not affected by infection. In plasma, albumin fractional synthesis rate was increased by 50% in infected animals compared with pair-fed animals. The albumin ASR estimated in the plasma was similar in the two groups. These results suggest that hypoalbuminemia is not due to reduced albumin synthesis during sepsis. Moreover, liver and plasma albumin ASR were similar. Therefore, albumin synthesis measured in the plasma is a good indicator of liver albumin synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913022     DOI: 10.1152/ajpendo.2000.279.2.E244

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  19 in total

Review 1.  A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist's perspective.

Authors:  Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2014-10-15       Impact factor: 3.064

2.  CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice.

Authors:  A S Gandhi; T Guo; P Shah; B Moorthy; D S-L Chow; M Hu; R Ghose
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Clinical chemistry of human FcRn transgenic mice.

Authors:  Carsten Stein; Lothar Kling; Gabriele Proetzel; Derry C Roopenian; Martin Hrabě de Angelis; Eckhard Wolf; Birgit Rathkolb
Journal:  Mamm Genome       Date:  2011-12-23       Impact factor: 2.957

4.  Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture.

Authors:  Elisabeth Fabian; Inge Gerstorfer; Heinrich W Thaler; Heinrich Stundner; Pia Biswas; Ibrahim Elmadfa
Journal:  Wien Klin Wochenschr       Date:  2011-01-21       Impact factor: 1.704

5.  A pharmacokinetic model for the glycation of albumin.

Authors:  Oskar Alskär; Julia Korell; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-04-21       Impact factor: 2.745

6.  Toxicological studies of "Chondrokola Rosh", an Ayurvedic preparation on liver function tests of rats.

Authors:  S Nasrin; S C Bachar; M S K Choudhuri
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

7.  Dynamics of albumin synthetic response to intra-abdominal abscess in patients with gastrointestinal fistula.

Authors:  Bo Zhou; Jianan Ren; Gang Han; Yu Chen; Jiye A; Guosheng Gu; Jun Chen; Gefei Wang; Jieshou Li
Journal:  Surg Infect (Larchmt)       Date:  2014-01-24       Impact factor: 2.150

8.  Adenovirus mediated expression "in vivo" of the chemokine receptor CXCR1.

Authors:  J Sarmiento; K E Kypreos; G N Prado; K Suetomi; C Stanzel; C Maxwell; D Shumate; M R Tandang-Silvas; K Rajarathnam; J Navarro
Journal:  J Struct Funct Genomics       Date:  2008-12-04

9.  Effect of splenectomy and autologous spleen transplantation on the serum platelet-activating factor acetylhydrolase (PAF-AH) activity and acute phase response (APR) in a porcine model.

Authors:  Romana Turk; Drazen Vnuk; Ante Svetina; Zlata Flegar-Mestrić; Zlata Flegar-Mestri; Mirna Robić; Mirna Robi; Nenad Turk; Vilim Staresina; Vlatko Rumenjak; Dubravka Juretić; Dubravka Jureti
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

10.  Exogenous albumin inhibits sorafenib-induced cytotoxicity in human cancer cell lines.

Authors:  Syu-Ichi Kanno; Katsuyuki Itoh; Naoto Suzuki; Ayako Tomizawa; Shin Yomogida; Masaaki Ishikawa
Journal:  Mol Clin Oncol       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.